Adipose tissue angiogenesis in obesity

 

 Buy Article Permissions and Reprints

summary

Adipose tissue is the most plastic tissue in all multicellular organisms, being constantly remodelled along with weight gain and weight loss. Expansion of adipose tissue must be accompanied by that of its vascularisation, through processes of angiogenesis, whereas weight loss is associated with the regression of blood vessels. Adipose tissue is thus among the tissues that have the highest angiogenic capacities. These changes of the vascular bed occur through close interactions of adipocytes with blood vessels, and involve several angiogenic factors. This review presents studies that are the basis of our understanding of the regulation of adipose tissue angiogenesis. The growth factors that are involved in the processes of angiogenesis and vascular regression are discussed with a focus on their potential modulation for the treatment of obesity. The hypothesis that inflammation of adipose tissue and insulin resistance could be related to altered angiogenesis in adipose tissue is presented, as well as the beneficial or deleterious effect of inhibition of adipose tissue angiogenesis on metabolic diseases.

• References

• 1 Olshansky SJ, Passaro DJ, Hershow RC. et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005; 352: 1138-1145.
  CrossrefPubMedGoogle Scholar
• 2 WHO. Obesity and overweight fact sheet. http://wwwwhoint/mediacentre/factsheets/fs311/en/ 2008 .
  PubMedGoogle Scholar
• 3 Cao R, Brakenhielm E, Wahlestedt C. et al. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA 2001; 98: 6390-6395.
  CrossrefPubMedGoogle Scholar
• 4 Sierra-Honigmann MR, Nath AK, Murakami C. et al. Biological action of leptin as an angiogenic factor. Science 1998; 281: 1683-1686.
  CrossrefPubMedGoogle Scholar
• 5 Ouchi N, Kobayashi H, Kihara S. et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 2004; 279: 1304-1309.
  CrossrefPubMedGoogle Scholar
• 6 Tang W, Zeve D, Suh JM. et al. White fat progenitor cells reside in the adipose vasculature. Science 2008; 322: 583-586.
  CrossrefPubMedGoogle Scholar
• 7 Powell K. Obesity: the two faces of fat. Nature 2007; 447: 525-527.
  CrossrefPubMedGoogle Scholar
• 8 Hausman GJ, Richardson RL. Adipose tissue angiogenesis. J Anim Sci 2004; 82: 925-934.
  CrossrefPubMedGoogle Scholar
• 9 Mandrup S, Loftus TM, MacDougald OA. et al. Obese gene expression at in vivo levels by fat pads derived from s.c. implanted 3T3-F442A preadipocytes. Proc Natl Acad Sci USA 1997; 94: 4300-4305.
  CrossrefPubMedGoogle Scholar
• 10 Vineberg AM, Shanks J, Pifarre R. et al. Myocardial Revascularization by Omental Graft without Pedicle: Experimental Background and Report on 25 Cases Followed 6 to 16 Months. J Thorac Cardiovasc Surg 1965; 49: 103-129.
  CrossrefPubMedGoogle Scholar
• 11 Beck CS. The Development of a New Blood Supply to the Heart by Operation. Ann Surg 1935; 102: 801-813.
  CrossrefPubMedGoogle Scholar
• 12 Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest 2007; 117: 2362-2368.
  CrossrefPubMedGoogle Scholar
• 13 Castellot Jr JJ, Karnovsky MJ, Spiegelman BM. Potent stimulation of vascular endothelial cell growth by differentiated 3T3 adipocytes. Proc Natl Acad Sci USA 1980; 77: 6007-6011.
  CrossrefPubMedGoogle Scholar
• 14 Goldsmith HS, Griffith AL, Kupferman A. et al. Lipid angiogenic factor from omentum. J Am Med Assoc 1984; 252: 2034-2036.
  CrossrefPubMedGoogle Scholar
• 15 Ledoux S, Queguiner I, Msika S. et al. Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes 2008; 57: 3247-3257.
  CrossrefPubMedGoogle Scholar
• 16 Silverman KJ, Lund DP, Zetter BR. et al. Angiogenic activity of adipose tissue. Biochem Biophys Res Commun 1988; 153: 347-352.
  CrossrefPubMedGoogle Scholar
• 17 Xue Y, Petrovic N, Cao R. et al. Hypoxia-independent angiogenesis in adipose tissues during cold acclimation. Cell Metab 2009; 9: 99-109.
  CrossrefPubMedGoogle Scholar
• 18 Voros G, Maquoi E, Demeulemeester D. et al. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 2005; 146: 4545-4554.
  CrossrefPubMedGoogle Scholar
• 19 Cho CH, Koh YJ, Han J. et al. Angiogenic role of LYVE-1-positive macrophages in adipose tissue. Circ Res 2007; 100: e47-e57.
  CrossrefPubMedGoogle Scholar
• 20 Zhang QX, Magovern CJ, Mack CA. et al. Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. J Surg Res 1997; 67: 147-154.
  CrossrefPubMedGoogle Scholar
• 21 Tam J, Duda DG, Perentes JY. et al. Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells. PLoS One 2009; 4: e4974.
  CrossrefPubMedGoogle Scholar
• 22 Olofsson B, Korpelainen E, Pepper MS. et al. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci USA 1998; 95: 11709-11714.
  CrossrefPubMedGoogle Scholar
• 23 Karkkainen MJ, Haiko P, Sainio K. et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004; 5: 74-80.
  CrossrefPubMedGoogle Scholar
• 24 Stacker SA, Caesar C, Baldwin ME. et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001; 7: 186-191.
  CrossrefPubMedGoogle Scholar
• 25 Carmeliet P, Moons L, Luttun A. et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7: 575-583.
  CrossrefPubMedGoogle Scholar
• 26 Lijnen HR, Christiaens V, Scroyen I. et al. Impaired adipose tissue development in mice with inactivation of placental growth factor function. Diabetes 2006; 55: 2698-2704.
  CrossrefPubMedGoogle Scholar
• 27 Bell LN, Ward JL, Degawa-Yamauchi M. et al. Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol Endocrinol Metab 2006; 291: E843-E848.
  CrossrefPubMedGoogle Scholar
• 28 Saiki A, Watanabe F, Murano T. et al. Hepatocyte growth factor secreted by cultured adipocytes promotes tube formation of vascular endothelial cells in vitro. Int J Obes 2006; 30: 1676-1684.
  CrossrefPubMedGoogle Scholar
• 29 Cohen B, Barkan D, Levy Y. et al. Leptin induces angiopoietin-2 expression in adipose tissues. J Biol Chem 2001; 276: 7697-7700.
  CrossrefPubMedGoogle Scholar
• 30 Ribatti D, Conconi MT, Nussdorfer GG. Nonclassic endogenous novel [corrected] regulators of angiogenesis. Pharmacol Rev 2007; 59: 185-205.
  CrossrefPubMedGoogle Scholar
• 31 Chavez RJ, Haney RM, Cuadra RH. et al. Upregulation of thrombospondin-1 expression by leptin in vascular smooth muscle cells via JAK2- and MAPK-dependent pathways. Am J Physiol Cell Physiol 2012; 303: C179-C191.
  CrossrefPubMedGoogle Scholar
• 32 Ekstrand AJ, Cao R, Bjorndahl M. et al. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc Natl Acad Sci USA 2003; 100: 6033-6038.
  CrossrefPubMedGoogle Scholar
• 33 Jamaluddin MS, Weakley SM, Yao Q. et al. Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol 2012; 165: 622-632.
  CrossrefPubMedGoogle Scholar
• 34 Cancello R, Henegar C, Viguerie N. et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005; 54: 2277-2286.
  CrossrefPubMedGoogle Scholar
• 35 Maisonpierre PC, Suri C, Jones PF. et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60.
  CrossrefPubMedGoogle Scholar
• 36 Neels JG, Thinnes T, Loskutoff DJ. Angiogenesis in an in vivo model of adipose tissue development. Faseb J 2004; 18: 983-985.
  CrossrefPubMedGoogle Scholar
• 37 Xue Y, Religa P, Cao R. et al. Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome. Proc Natl Acad Sci USA 2008; 105: 18513-1818.
  CrossrefPubMedGoogle Scholar
• 38 Samad F, Pandey M, Loskutoff DJ. Tissue factor gene expression in the adipose tissues of obese mice. Proc Natl Acad Sci USA 1998; 95: 7591-7596.
  CrossrefPubMedGoogle Scholar
• 39 Lebrin F, Deckers M, Bertolino P. et al. TGF-beta receptor function in the endothelium. Cardiovasc Res 2005; 65: 599-608.
  CrossrefPubMedGoogle Scholar
• 40 Brakenhielm E, Veitonmaki N, Cao R. et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA 2004; 101: 2476-2481.
  CrossrefPubMedGoogle Scholar
• 41 Maeda N, Shimomura I, Kishida K. et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8: 731-737.
  CrossrefPubMedGoogle Scholar
• 42 Agah A, Kyriakides TR, Lawler J. et al. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol 2002; 161: 831-839.
  CrossrefPubMedGoogle Scholar
• 43 Schneider DJ, Sobel BE. PAI-1 and diabetes: a journey from the bench to the bedside. Diabetes Care 2012; 35: 1961-1967.
  CrossrefPubMedGoogle Scholar
• 44 Devy L, Blacher S, Grignet-Debrus C. et al. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. Faseb J 2002; 16: 147-154.
  CrossrefPubMedGoogle Scholar
• 45 Alessi MC, Bastelica D, Morange P. et al. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 2000; 49: 1374-1380.
  CrossrefPubMedGoogle Scholar
• 46 Lijnen HR. Effect of plasminogen activator inhibitor-1 deficiency on nutritionally-induced obesity in mice. Thromb Haemost 2005; 93: 816-819.
  Article in Thieme ConnectPubMedGoogle Scholar
• 47 Varma V, Yao-Borengasser A, Bodles AM. et al. Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabetes 2008; 57: 432-439.
  CrossrefPubMedGoogle Scholar
• 48 Papetti M, Herman IM. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 2002; 282: C947-C970.
  CrossrefPubMedGoogle Scholar
• 49 Katsuki A, Sumida Y, Murashima S. et al. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998; 83: 859-862.
  PubMedGoogle Scholar
• 50 Fasshauer M, Klein J, Neumann S. et al. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2002; 290: 1084-1089.
  CrossrefPubMedGoogle Scholar
• 51 Rega G, Kaun C, Demyanets S. et al. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo. Arterioscler Thromb Vasc Biol 2007; 27: 1587-1595.
  CrossrefPubMedGoogle Scholar
• 52 Rega G, Kaun C, Weiss TW. et al. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue. Circulation 2005; 111: 1938-1945.
  CrossrefPubMedGoogle Scholar
• 53 Bouloumie A, Sengenes C, Portolan G. et al. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 2001; 50: 2080-2086.
  CrossrefPubMedGoogle Scholar
• 54 Lijnen HR, Juhan-Vague I. The fibrinolytic system and obesity. Thromb Haemost 2002; 88: 882.
  Article in Thieme ConnectPubMedGoogle Scholar
• 55 Maquoi E, Munaut C, Colige A. et al. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 2002; 51: 1093-1101.
  CrossrefPubMedGoogle Scholar
• 56 Liu J, Sukhova GK, Sun JS. et al. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 1359-1366.
  CrossrefPubMedGoogle Scholar
• 57 Im E, Venkatakrishnan A, Kazlauskas A. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. Mol Biol Cell 2005; 16: 3488-3500.
  CrossrefPubMedGoogle Scholar
• 58 Alvarez-Llamas G, Szalowska E, de Vries MP. et al. Characterization of the human visceral adipose tissue secretome. Mol Cell Proteomics 2007; 6: 589-600.
  CrossrefPubMedGoogle Scholar
• 59 Voros G, Maquoi E, Collen D. et al. Differential expression of plasminogen activator inhibitor-1, tumor necrosis factor-alpha, TNF-alpha converting enzyme and ADAMTS family members in murine fat territories. Biochim Biophys Acta 2003; 1625: 36-42.
  CrossrefPubMedGoogle Scholar
• 60 Rupnick MA, Panigrahy D, Zhang CY. et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 2002; 99: 10730-10735.
  CrossrefPubMedGoogle Scholar
• 61 Lemoine AY, Ledoux S, Queguiner I. et al. Link between adipose tissue angiogenesis and fat accumulation in severely obese subjects. J Clin Endocrinol Metab 2012; 97: E775-E780.
  CrossrefPubMedGoogle Scholar
• 62 Villaret A, Galitzky J, Decaunes P. et al. Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes 2010; 59: 2755-2763.
  CrossrefPubMedGoogle Scholar
• 63 Pasarica M, Rood J, Ravussin E. et al. Reduced oxygenation in human obese adipose tissue is associated with impaired insulin suppression of lipolysis. J Clin Endocrinol Metab 2010; 95: 4052-4055.
  CrossrefPubMedGoogle Scholar
• 64 Halberg N, Khan T, Trujillo ME. et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 2009; 29: 4467-4483.
  CrossrefPubMedGoogle Scholar
• 65 Brahimi-Horn MC, Chiche J, Pouyssegur J. Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol 2007; 19: 223-229.
  CrossrefPubMedGoogle Scholar
• 66 Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes 2009; 33: 54-66.
  CrossrefPubMedGoogle Scholar
• 67 Hosogai N, Fukuhara A, Oshima K. et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007; 56: 901-911.
  CrossrefPubMedGoogle Scholar
• 68 Hodson L, Humphreys SM, Karpe F. et al. Metabolic Signatures of Human Adipose Tissue Hypoxia in Obesity. Diabetes. 2012. Epub ahead of print.
  Google Scholar
• 69 Spencer M, Unal R, Zhu B. et al. Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. J Clin Endocrinol Metab 2011; 96: E1990-E1998.
  CrossrefPubMedGoogle Scholar
• 70 Gealekman O, Guseva N, Hartigan C. et al. Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation 2011; 123: 186-194.
  CrossrefPubMedGoogle Scholar
• 71 Ledoux S, Coupaye M, Essig M. et al. Traditional anthropometric parameters still predict metabolic disorders in women with severe obesity. Obesity 2009; 18: 1026-1032.
  CrossrefPubMedGoogle Scholar
• 72 Cancello R, Tordjman J, Poitou C. et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006; 55: 1554-1561.
  CrossrefPubMedGoogle Scholar
• 73 Poitou C, Divoux A, Faty A. et al. Role of serum amyloid a in adipocyte-macrophage cross talk and adipocyte cholesterol efflux. J Clin Endocrinol Metab 2009; 94: 1810-1817.
  CrossrefPubMedGoogle Scholar
• 74 Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med 2006; 119 (05) (Suppl. 01) S10-S16.
  CrossrefPubMedGoogle Scholar
• 75 Slawik M, Vidal-Puig AJ. Adipose tissue expandability and the metabolic syndrome. Genes Nutr 2007; 2: 41-45.
  CrossrefPubMedGoogle Scholar
• 76 Jonker JW, Suh JM, Atkins AR. et al. A PPARgamma-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. Nature 2012; 485: 391-394.
  CrossrefPubMedGoogle Scholar
• 77 Tan BK, Adya R, Chen J. et al. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1. Cardiovasc Res 2009; 83: 566-574.
  CrossrefPubMedGoogle Scholar
• 78 Trayhurn P, Wang B, Wood IS. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?. Br J Nutr 2008; 100: 227-235.
  CrossrefPubMedGoogle Scholar
• 79 Goossens GH, Bizzarri A, Venteclef N. et al. Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation. Circulation 2011; 124: 67-76.
  CrossrefPubMedGoogle Scholar
• 80 Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest 2011; 121: 2094-2101.
  CrossrefPubMedGoogle Scholar
• 81 Cinti S, Mitchell G, Barbatelli G. et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005; 46: 2347-2355.
  CrossrefPubMedGoogle Scholar
• 82 Sacks FM, Bray GA, Carey VJ. et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009; 360: 859-873.
  CrossrefPubMedGoogle Scholar
• 83 Sjostrom L, Narbro K, Sjostrom CD. et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752.
  CrossrefPubMedGoogle Scholar
• 84 Dietrich MO, Horvath TL. Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons. Nat Rev Drug Discov 2012; 11: 675-691.
  CrossrefPubMedGoogle Scholar
• 85 Brakenhielm E, Cao R, Gao B. et al. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res 2004; 94: 1579-1588.
  CrossrefPubMedGoogle Scholar
• 86 Barnhart KF, Christianson DR, Hanley PW. et al. A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys. Sci Transl Med 2011; 3: 108ra12.
  CrossrefPubMedGoogle Scholar
• 87 Sun K, Wernstedt Asterholm I, Kusminski CM. et al. Dichotomous effects of VEGF-A on adipose tissue dysfunction. Proc Natl Acad Sci USA 2012; 109: 5874-5879.
  CrossrefPubMedGoogle Scholar
• 88 Kim DH, Sartor MA, Bain JR. et al. Rapid and weight-independent improvement of glucose tolerance induced by a peptide designed to elicit apoptosis in adipose tissue endothelium. Diabetes 2012; 61: 2299-2310.
  CrossrefPubMedGoogle Scholar
• 89 Sung HK, Doh KO, Son JE. et al. Adipose Vascular Endothelial Growth Factor Regulates Metabolic Homeostasis through Angiogenesis. Cell Metab 2013; 17: 61-72.
  CrossrefPubMedGoogle Scholar
• 90 Mori Y, Murakawa Y, Okada K. et al. Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care 1999; 22: 908-912.
  CrossrefPubMedGoogle Scholar
• 91 Gealekman O, Guseva N, Gurav K. et al. Effect of rosiglitazone on capillary density and angiogenesis in adipose tissue of normoglycaemic humans in a randomised controlled trial. Diabetologia 2012; 55: 2794-2799.
  CrossrefPubMedGoogle Scholar
• 92 Duh E, Aiello LP. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 1999; 48: 1899-1906.
  CrossrefPubMedGoogle Scholar
• 93 Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature 2005; 438: 960-966.
  CrossrefPubMedGoogle Scholar
• 94 Hurwitz H, Fehrenbacher L, Novotny W. et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342.
  CrossrefPubMedGoogle Scholar
• 95 Celletti FL, Waugh JM, Amabile PG. et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001; 7: 425-429.
  CrossrefPubMedGoogle Scholar
• 96 Ware JA. Too many vessels? Not enough? The wrong kind? The VEGF debate continues. Nat Med 2001; 7: 403-404.
  CrossrefPubMedGoogle Scholar